58 related articles for article (PubMed ID: 3930286)
1. [Blood prolactin-lowering activity of dihydroergocristine].
Cocchi D; Müller EE; Boselli P; Faini D
Farmaco Sci; 1985 Jul; 40(7):534-40. PubMed ID: 3930286
[TBL] [Abstract][Full Text] [Related]
2. Prolactin lowering effect of dihydroergokryptine in rat and in man.
Poli M; Cocchi D; Mailland F; Masu AM; Landi G; Craveri A; Müller EE
J Endocrinol Invest; 1986 Feb; 9(1):31-6. PubMed ID: 3084616
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of sulpiride-induced prolactin secretion by dihydroergocristine in man.
Poli M; Caviezel F; Girardi AM; Bosi E; Pozza G
Adv Biochem Psychopharmacol; 1980; 24():445-9. PubMed ID: 6773304
[No Abstract] [Full Text] [Related]
4. Effect of dihydroergocryptine and dihydroergocristine on cyclic AMP accumulation and prolactin release in vitro: evidence for a dopaminomimetic action.
Fiore L; Scapagnini U; Canonico PL
Horm Res; 1987; 25(3):171-7. PubMed ID: 3032757
[TBL] [Abstract][Full Text] [Related]
5. [Effect of co-dergocrine mesylate on catecholamines and prolactin in elderly hypertensive patients].
Mies R; Lang R; Weidinger G; Welzel D
Arzneimittelforschung; 1983; 33(5):771-3. PubMed ID: 6683557
[TBL] [Abstract][Full Text] [Related]
6. Dihydroergocryptine protects from acute experimental allergic encephalomyelitis in the rat.
Canonico PL; Sortino MA; Favit A; Aleppo G; Scapagnini U
Funct Neurol; 1993; 8(3):183-8. PubMed ID: 8406136
[TBL] [Abstract][Full Text] [Related]
7. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
Tresguerres JA; Esquifino AI
Acta Physiol Lat Am; 1983; 33(3):257-74. PubMed ID: 6424409
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of norepinephrine- and 5-hydroxytryptamine-induced contraction on rat aorta by dihydroergocristine.
D'Agostino G; Dondi G; Zonta F; Grana E
Farmaco Sci; 1984 Mar; 39(3):208-16. PubMed ID: 6425080
[TBL] [Abstract][Full Text] [Related]
9. Measuring the inhibition of TRH-stimulated prolactin by dihydroergocristine (DEC) in man: an indirect assessment of bioavailability.
Venitz J; Lücker PW; Albrecht H; Mailland F
Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):645-7. PubMed ID: 6439963
[TBL] [Abstract][Full Text] [Related]
10. [Alpha-blocking activity of raubasine-dihydroergocristine combination in the demedullated rat].
Roquebert J; Gomond P; Demichel P
Ann Pharm Fr; 1983; 41(1):69-75. PubMed ID: 6137989
[No Abstract] [Full Text] [Related]
11. Cimetidine and prolactin: a study with dihydroergocristine.
Poli M; Caviezel F; Bosi E; Murari M; Bonetti M
Horm Metab Res; 1982 Nov; 14(11):616-7. PubMed ID: 6818118
[No Abstract] [Full Text] [Related]
12. Inhibition of prolactin secretion in rats with the ergoline derivative deprenon.
Chlebounová J; Seda M; Fingerová H; Rezábek K
Arzneimittelforschung; 1980; 30(6):956-8. PubMed ID: 7191272
[TBL] [Abstract][Full Text] [Related]
13. Circadian rhythms in plasma prolactin, luteinizing hormone and hypophyseal prolactin levels in lactating rats.
Kacsóh B; Nagy G
Endocrinol Exp; 1983 Oct; 17(3-4):301-10. PubMed ID: 6606568
[TBL] [Abstract][Full Text] [Related]
14. Effect of apomorphine on serum prolactin level in the male.
Brown WA
Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):671-4. PubMed ID: 1179038
[TBL] [Abstract][Full Text] [Related]
15. [Action of dihydroergocristine at pre- and postsynaptic alpha-adrenoceptors in the rat isolated vas deferens].
Roquebert J; Demichel P; Gomond P; Malek A
J Pharmacol; 1983; 14(2):151-9. PubMed ID: 6134866
[TBL] [Abstract][Full Text] [Related]
16. Rapid decrease of plasma prolactin levels in lactating rats separated from their pups.
Nagy G; Bánky Z; Takács L
Endocrinol Exp; 1983 Oct; 17(3-4):311-6. PubMed ID: 6606569
[TBL] [Abstract][Full Text] [Related]
17. [Dihydroergocristine. A review of pharmacology and toxicology].
Coppi G
Arzneimittelforschung; 1992 Nov; 42(11A):1381-90. PubMed ID: 1492857
[TBL] [Abstract][Full Text] [Related]
18. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
[TBL] [Abstract][Full Text] [Related]
19. Influence of some ergot alkaloids on the cerebral reduced glutathione.
Gorini A; Arnaboldi R; Vercesi L; Dossena M
Farmaco Sci; 1988 Nov; 43(11):887-90. PubMed ID: 3150835
[TBL] [Abstract][Full Text] [Related]
20. hyperprolactinemia of portal hypertension in rats.
Bauer AG; de Greef WJ; de Jong FH; Wilson JH; Lamberts SW
Gastroenterology; 1982 Feb; 82(2):179-83. PubMed ID: 7054021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
